vidarabine phosphate has been researched along with Lymphoma, Follicular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buy, E; Cany, L; Eghbali, H; Guibon, O; Hoerni, B; Kind, M; Monnereau, A; Soubeyran, I; Soubeyran, P | 1 |
| Bastion, Y; Bordessoule, D; Bosly, A; Brice, P; Brousse, N; Caspard, H; Dupas, B; Fort, N; Haïoun, C; Harousseau, JL; Leporrier, M; Morel, P; Plassart, F; Sebban, C; Solal-Céligny, P; Tilly, H; Vasile, N | 1 |
2 trial(s) available for vidarabine phosphate and Lymphoma, Follicular
| Article | Year |
|---|---|
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphoma, Follicular; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Survival Analysis; Treatment Outcome; Vidarabine Phosphate; Vincristine | 2005 |
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Treatment Outcome; Vidarabine Phosphate | 1996 |